Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 1Thrombocytopenia 1Precancerous Conditions 1Pathologic Complete Response 1Ovarian Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Colposcopy 5Polymerase Chain Reaction 4Biopsy 4Watchful Waiting 2Vaginal Smears 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Histological Techniques 2Cidofovir 2human papillomavirus vaccine, TA 1human papillomavirus vaccine, L1 type 16, 18 1Zoledronic Acid 1Tretinoin 1Transurethral Resection of Prostate 1Spectrum Analysis 1Spectrometry, Fluorescence 1Sodium Chloride 1Robotic Surgical Procedures 1Radiotherapy 1Pregnancy Tests 1Papanicolaou Test 1Mindfulness-Based Stress Reduction 1Microarray Analysis 1Immunohistochemistry 1Hysterectomy 1Human Papillomavirus DNA Tests 1Gene Expression Profiling 1Folic Acid 1Fluorophotometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Tretinoin × Gynecologic × Clear all
NCT00003598 2010-09-22

IRB 1996-0189

University of Michigan Rogel Cancer Center

Phase NA Completed
180 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡